DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Nihonbashi Life Science HUB

2026年7月30日 (木) 午後 1:00 - 2026年7月30日 (木) 午後 8:00

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

6th DIA COMMUNITY DAY

概要

6th Community Day will be conducted in Japanese Language only.

Click Here to View the Flyer in Japanese

 

プログラム委員会

  • Kotone  Matsuyama, RPH
    Kotone Matsuyama, RPH Center for Clinical Research and Development
    National Center for Child Health and Development, Japan
  • So  Miyoshi
    So Miyoshi Head of Clinical Pharmacology & Bioanalytics
    Pfizer R&D Japan, Japan
  • Keiko  Tsumori, MSC
    Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
    MSD K.K., Japan
  • Naoki  Isogawa, PHD
    Naoki Isogawa, PHD Biometrics & Quantitative Sciences East Asia (BQS), Head of BQS East Asia
    UCB Japan Co., Ltd., Japan
  • Yoichi M.  Ito, PHD
    Yoichi M. Ito, PHD Director
    Hokkaido University Hospital, Institute of Health Science Innovation, Japan
  • Masaaki  Jitsu
    Masaaki Jitsu
    Bayer Yakuhin Ltd, Japan
  • Yusuke  Kajimoto
    Yusuke Kajimoto Senior Scientist, Scientific Affairs
    MSD K.K., Japan
  • Keiko  Katsui, PHD
    Keiko Katsui, PHD Division of Biomedical Ethics and Social Co-Creation
    Japan Agency for Medical Research and Development (AMED), Japan
  • Kentaro  Kogushi, PHD
    Kentaro Kogushi, PHD Head of Clinical Development Neurology-Psychiatry, Japan Development
    AbbVie GK, Japan
  • Misato  Kuwagaki, MS
    Misato Kuwagaki, MS Associate Director, Japan Data Sciences, Medical Sciences
    Eli Lilly Japan K.K., Japan
  • Mika  Maeda
    Mika Maeda Lecturer, Section for Human Research Protections, Kitasato University Hospital
    School of Pharmacy, Kitasato University, Japan
  • Kana  Maruyama
    Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
    Viatris Pharmaceuticals Japan GK, Japan
  • Makoto  Nagaoka, PHD
    Makoto Nagaoka, PHD Senior Director, Global Regulatory Affairs Strategy, Consulting
    Fortrea Japan K.K., Japan
  • Tomoharu  Numanyu, RPH
    Tomoharu Numanyu, RPH Senior Reviewer, Office of New Drug I
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Hiromi  Okabe, PHD
    Hiromi Okabe, PHD Oncology & Rare Disease, Regulatory Strategy, Regulatory Affairs
    Amgen K.K., Japan
  • Daiju  Okuda, PHARMD
    Daiju Okuda, PHARMD Deputy Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Takashi  Sato, MSC, PMP
    Takashi Sato, MSC, PMP
    PM Orchestra Takashi Sato, Japan
  • Keisuke  Suzuki, PHD
    Keisuke Suzuki, PHD Director, Innovation Center for Translational Research
    National Center for Geriatrics and Gerontology, Japan
  • Satoshi  Suzuki, PMP
    Satoshi Suzuki, PMP Director, Head of PM Office Group, Japan Portfolio & Project Management
    Pfizer R&D Japan G.K., Japan
  • Tadashi  Urashima, PHD
    Tadashi Urashima, PHD Performance and Digital Analytics Lead, Japan Development
    GlaxoSmithKline K.K., Japan
  • Miyoko  Yamauchi
    Miyoko Yamauchi Head, Human Capital Development Group
    CHUGAI PHARMACEUTICAL CO., LTD., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。